Highly labeled methylene blue-ds DNA silica nanoparticles for signal enhancement of immunoassays: application to the sensitive detection of bacteria in human platelet concentrates

The Analyst ◽  
2018 ◽  
Vol 143 (10) ◽  
pp. 2293-2303 ◽  
Author(s):  
Romaric Bonnet ◽  
Carole Farre ◽  
Lionel Valera ◽  
Ludivine Vossier ◽  
Fanny Léon ◽  
...  

A nanoparticle-based electrochemical immunoassay for bacteria detection in platelet concentrates.

The Analyst ◽  
2015 ◽  
Vol 140 (23) ◽  
pp. 7948-7954 ◽  
Author(s):  
Ai-Li Sun

A new electrochemical immunosensor with signal enhancement was designed for sensitive detection of disease-related protein (human carbohydrate antigen 19-9, CA 19-9 used in this case).


Transfusion ◽  
1991 ◽  
Vol 31 (3) ◽  
pp. 286-286 ◽  
Author(s):  
WJ Judd ◽  
EA Steiner ◽  
V Miske

2021 ◽  
Author(s):  
Xuelian Xiang ◽  
Yanlin Wang ◽  
Yanhui Zhang ◽  
Ruo Yuan ◽  
Shangping Wei

Herein, bismuth oxyiodide (Bi5O7I) was used as a signal probe to construct an effective sensitization structure with methylene blue (MB), combined with protein conversion strategy, and a photoelectrochemical (PEC) biosensor was constructed...


1996 ◽  
Vol 29 (1) ◽  
pp. 47-49 ◽  
Author(s):  
Hélio Moraes-Souza ◽  
José Orlando Bordin ◽  
Leslie Bardossy ◽  
Morris A. Blajchman

The present measures adopted to prevent transfusion-associated Chagas' disease include screening of blood donors. and/or the inactivation of T. cruzi in collected blood using gentian violet (GV) as a trypanocidal agent. In this study, we investigated the efficacy of the combined use of AMT and UV-A in inactirating T. cruzi in infected human platelet cuncentrates. Human platelet concentrates were infected with T. cruzi (2x10/ml) of the Y strain transfered to PL 269 (Fenwal Laboratories) containers and treated with GV (250řg,/ml). and ascorbic acid (1 mg/ml); GV. ascorbic acid and UV-A; GV and UV-A; AMT (40/tG/ml) and ascorbic acid; AMT, ascorbic acid and UV-A; AMT and UV-A; UV-A alone; and untreated (control). All UV-A treated platelet concentrates were exposed to UV-A doses of 24, 92, 184, 276, 368 and 644 kj/m². and the microscopical research of active T. cruzi was performed, using the microhematocrit technique, 1, 6 and 24 hours after each treatment. A high number of active forms of T. cruzi was observed in all condictions, except when GV was used as the trypanocidal agent, providing evidence of the failure of AMT and UV-A in inactivating T cruzi in infected human platelet concentrates.


Transfusion ◽  
2002 ◽  
Vol 42 (6) ◽  
pp. 711-718 ◽  
Author(s):  
Valery Leytin ◽  
David J. Allen ◽  
Meera Mody ◽  
Margaret L. Rand ◽  
Barbara Hannach ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document